Two Japanese patients with stage G3b chronic kidney disease and impaired glucose metabolism after re...
Two Japanese patients with stage G3b chronic kidney disease and impaired glucose metabolism after renal transplantation successfully treated with empagliflozin
About this item
Full title
Author / Creator
Publisher
London: Springer
Journal title
Language
English
Formats
Publication information
Publisher
London: Springer
Subjects
More information
Scope and Contents
Contents
Background Renal transplant recipients with chronic kidney disease (CKD) often develop abnormal glucose metabolism. Although recent studies have reported the protective effects of sodium-glucose transport protein 2 (SGLT2) inhibitors on the heart and kidneys, few have assessed their effect in renal transplant patients. Moreover, to our knowledge, t...
Alternative Titles
Full title
Two Japanese patients with stage G3b chronic kidney disease and impaired glucose metabolism after renal transplantation successfully treated with empagliflozin
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d3d4f07126ea46d390a477cb8d6cc890
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d3d4f07126ea46d390a477cb8d6cc890
Other Identifiers
ISSN
2059-1381
E-ISSN
2059-1381
DOI
10.1186/s41100-020-00303-x
